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The mature arenavirus envelope glycoprotein GPC is a tripartite complex comprising a stable signal peptide
(SSP) in addition to the receptor-binding (G1) and transmembrane fusion (G2) subunits. We have shown
previously that SSP is a key element in GPC-mediated membrane fusion, and that GPC sensitivity to acidic pH
is modulated in part through the lysine residue at position 33 in the ectodomain loop of SSP (J. York and J. H.
Nunberg, J. Virol. 80:7775–7780, 2006). A glutamine substitution at this position stabilizes the native GPC
complex and thereby prevents the induction of pH-dependent membrane fusion. In efforts to identify the
intersubunit interactions of K33, we performed alanine-scanning mutagenesis at charged residues in the
membrane-proximal ectodomain of G2 and determined the ability of these mutations to rescue the fusion
deficiency in K33Q GPC. Four second-site mutations that specifically complement K33Q were identified
(D400A, E410A, R414A, and K417A). Moreover, complementation was also observed at three hydrophobic
positions in the membrane-spanning domain of G2 (F427, W428, and F438). Interestingly, all of the complementing mutations restored wild-type pH sensitivity to the K33Q mutant, while none themselves affected the
pH of membrane fusion. Our studies demonstrate a specific interaction between SSP and G2 that is involved
in priming the native GPC complex for pH-induced membrane fusion. Importantly, this pH-dependent interaction has been shown to be vulnerable to small-molecule compounds that stabilize the native complex and
prevent the activation of membrane fusion. A detailed mechanistic understanding of the control of GPCmediated membrane fusion will be important in guiding the development of effective therapeutics against
arenaviral hemorrhagic fever.
1). The 58-amino-acid SSP spans the membrane twice, with
both termini in the cytosol (1), and likely is retained in the
complex by the formation of an intersubunit zinc finger structure with the cytoplasmic domain of G2 (46). Importantly, we
have shown that the short ectodomain loop of SSP plays a
central role in the response of the GPC complex to acidic pH
and, thereby, in pH-dependent membrane fusion (44, 47). Despite the unusual involvement of SSP in pH-triggered activation, the subsequent mechanics of GPC-mediated membrane
fusion are likely similar to those of other class I viral fusion
proteins, such as influenza virus hemagglutinin (HA) and the
retrovirus envelope glycoprotein (Env) (17, 20, 43). A generally accepted model for membrane fusion by these proteins
(reviewed in references 14, 22, and 42) posits that the native
envelope glycoprotein exists in a metastable prefusion state
that is established on proteolytic maturation. Destabilization of
the native complex by acidic pH in HA (or receptor binding by
Env) initiates a sequence of conformational changes that ultimately lead to formation of the now-classical six-helix bundle
structure in the ectodomain of the transmembrane fusion subunit. In the process of forming this highly stable postfusion
structure, the virus and cell membranes are brought into apposition and membrane fusion ensues. HA is the best-studied
pH-dependent class I fusion protein, but even though the prefusion and postfusion structures are known in atomic detail,
the molecular basis for the pH-induced activation of the complex remains elusive (14, 22, 42).
Our previous studies of JUNV GPC identified the unusual
role of SSP in modulating the response of GPC to acidic pH.
We demonstrated that mutations that reduce the positive charge
at lysine 33 (K33) in the ectodomain loop of SSP correspondingly

Arenaviruses are endemic in rodent populations worldwide
(37), and several species of the virus can be transmitted to
humans to cause severe hemorrhagic fevers (30, 33). These
include Lassa fever virus (LASV) in western Africa and Junín
virus (JUNV) in the New World. The arenaviruses are enveloped, negative-strand RNA viruses whose bipartite genomes
encode the ambisense expression of the four viral proteins (7,
10). The envelope glycoprotein GPC promotes virus entry into
the host cell and thereby provides a viable target for therapeutic intervention (3, 27, 28, 44). GPC is synthesized as a precursor glycoprotein that is proteolytically matured by the cellular
SKI-1/S1P protease (2, 26, 29) to generate the receptor-binding (G1) and transmembrane fusion (G2) subunits, which remain noncovalently associated in the mature complex. Arenavirus entry is initiated by G1 binding to a cell surface receptor.
The pathogenic New World arenaviruses utilize transferrin
receptor-1 for entry (34, 35), whereas Old World viruses bind
␣-dystroglycan (8, 18, 38). The virion subsequently is endocytosed (4), and fusion of the viral and cellular membranes is
initiated by acidification in the maturing endosome (9, 12, 13).
The details of the acid-induced activation of GPC-mediated
membrane fusion are unknown.
The arenavirus GPC is unique among viral envelope glycoproteins in that the mature complex includes a cleaved and
stable signal peptide (SSP) as a third subunit (6, 15, 48) (Fig.
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FIG. 1. Arenavirus GPC complex. The JUNV GPC open reading frame is illustrated at the top. Amino acids are numbered from the initiating
methionine, and the SSP, G1, and G2 subunits are indicated. Membrane-spanning regions in SSP (h1 and h2; 1) and in G2 (TM) are shaded
dark gray, and the N- and C-terminal heptad repeat regions in G2 (43) are in light gray. The amino acid sequence of the G2 membrane-proximal
ectodomain and transmembrane domain (shaded) of JUNV is detailed below; positions studied in this report are indicated by dots. At the lower
right is a diagram of the proposed subunit organization in the tripartite GPC complex. Thickened lines represent membrane-spanning domains in
SSP and G2 and the heptad repeat regions in G2. The cytosolic N terminus of SSP is myristoylated (thin line) (48), and an intersubunit zinc finger
(ball) is thought to link the C terminus of SSP with the cytoplasmic domain of G2 (46). Lysine 33 (K33) in SSP is marked. The drawing is
representational and not to scale. In the lower left, we show the alignment of the arenavirus membrane-proximal G2 ectodomain regions. Accession
numbers are the following: JUNV, D10072; LASV-Nigeria (LASV-N), P17332; Tacaribe virus (TCRV), NP_694849; Pichinde virus (PICV),
AAB58484; Machupo virus (MACV), AAX99337; Sabiá virus (SABV), AAC55091; LASV-Josiah (LASV-J), AAG41802; Mopeia virus (MOPV),
AAV54108; and lymphocytic choriomeningitis virus-Armstrong (LCMV-A), NP_694851. Charged residues are highlighted in blue (basic) or red
(acidic).

stabilize GPC against pH-induced activation (47). Based on this
finding, we sought to identify the pH-responsive elements in
GPC with which K33 interacts. In the absence of structural
information, we directed our investigation to the membraneproximal ectodomain and transmembrane regions of G2,
which may lie near the membrane-proximal K33 residue in
SSP. By using the method of genetic complementation, we now
have identified second-site mutations in G2 that rescue the
fusion deficiency arising from the substitution of K33 with
glutamine. Our findings provide evidence that SSP and G2
interact in controlling the pH-induced activation of GPC-mediated membrane fusion.
MATERIALS AND METHODS
Molecular reagents. GPC from the pathogenic JUNV strain MC2 (21) was
expressed in Vero cells by the Lipofectamine 2000 (Invitrogen)-mediated cotransfection of two plasmids: CD4sp-GPC (in which SSP is replaced by the
conventional signal peptide of CD4) and SSP-term (in which a stop codon is
introduced following the C-terminal SSP amino acid T58) (47). SSP and the
G1-G2 precursor associate in trans and reconstitute the native GPC complex
(15). This experimental system obviates concerns regarding the potential effects
of mutation on the signal peptidase cleavage of full-length GPC (45). Mutations
in GPC were introduced by QuikChange mutagenesis (Stratagene), and all
constructs were verified by DNA sequencing.
Cell-cell fusion assay. A vaccinia virus-based ␤-galactosidase fusion reporter
assay (31) was used to characterize the ability of GPC to mediate pH-dependent
cell-cell fusion (47, 48). Briefly, Vero cells expressing GPC and infected by vTF-7
(which expresses bacteriophage T7 polymerase) (19) were maintained in medium
containing 10 M cytosine arabinoside (araC) to limit vaccinia virus replication.
Target cells for syncytium formation were infected with a recombinant vaccinia
virus bearing the ␤-galactosidase gene under the control of a T7 promoter
(vCB21R-lacZ) (31) and subsequently were seeded into 96-well microculture
dishes (40,000 cells/well) in the presence of 100 g rifampin/ml to minimize
vaccinia assembly and cytopathic effect (24). Prior to use in the cell-cell fusion

assay, target cells (40,000 cells/well) were added to the microcultures, allowed to
settle for 30 min, and subjected to a brief low-speed centrifugation (⬃25 ⫻ g) to
ensure cell-cell contact. These cocultures were continued for 3 h in medium
containing araC and rifampin. Membrane fusion was initiated by incubation in
medium that had been adjusted to low pH using HEPES and piperazine-N,N⬘bis(2-ethanesulfonic acid) buffers. After 10 min at 37°C, the cells were restored
to neutral medium and cultured for 5 h to allow for the expression of the
␤-galactosidase fusion reporter gene, which then was quantitated using the
chemiluminescent GalactoLite Plus substrate (Applied Biosystems) and a Tropix
TR717 microplate luminometer.

RESULTS AND DISCUSSION
The pH-induced activation of GPC-mediated membrane fusion is controlled in part by the lysine at position 33 in the short
ectodomain loop of SSP. Amino acid substitutions that reduce
positive polarity at K33 systematically lower the pH necessary
to activate membrane fusion (47). The replacement of lysine
with glutamine (K33Q) reduces membrane fusion activity to
6% of the wild-type level (see below) while decreasing the pH
of maximal fusion from the wild-type optimum of pH 5.0 to pH
4.5. The apparent stabilization of the mutant complex against
acidic pH does not appreciably affect its intrinsic fusion activity, as K33Q GPC retains (at pH 4.5) as much as 40 to 50% of
the wild-type GPC activity (at pH 5.0). The replacement of
K33 with alanine not only abrogates membrane fusion at any
relevant pH but also stabilizes the complex against spontaneous dissociation of the G1 and G2 subunits (44). In order to
identify pH-sensitive determinants that might interact with
K33, we inspected the amino acid sequence of the membraneproximal ectodomain of G2. This region, within 35 amino acids
of the membrane (D390 to D424 in JUNV), includes 12
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FIG. 2. Membrane fusion activity of G2 mutants. The wild-type
(wt) and G2 mutants in CD4sp-GPC were expressed in trans with
wild-type SSP (open bars) or K33Q SSP (filled bars). The ability of the
single and double mutants to mediate cell-cell fusion at pH 5.0 was
determined as detailed in Materials and Methods. Error bars representing ⫾1 standard deviation are calculated for all points (n ⫽ 6) and
may not be visible on the scale of the graph. These data represent one
complete study (of at least three to six complete and partial experiments). All comparisons are reliably reproducible between experiments, although absolute percentages may vary. The average for K33Q
GPC (6.1% ⫾ 2.5%) differs from that previously cited (47) due to
technical changes in the assay. The D400A, E405A, E410A, K417A,
and D424A mutants have been reported previously (44).

charged residues in both JUNV and LASV (Fig. 1). Nine of
these (D394, D400, E405, K409, E410, D413, R414, K417, and
D424) are identical between the two viruses. Other positions
vary conservatively among New World and Old World arenaviruses, and all species retain ⱖ30% charged residues (Fig. 1).
Only R414 and D424 are invariant among all of the arenaviruses.
The role of these charged residues in membrane fusion
was examined by replacing them individually with alanine.
In brief, mutations were introduced into a recombinant construct, CD4sp-GPC, encoding the G1-G2 precursor of the
pathogenic MC2 isolate of JUNV (21) preceded by the conventional signal peptide of CD4 (48). When transiently coexpressed with SSP (amino acids 1 to 58) in Vero cells, the GPC
complex is functionally reconstituted (15, 48). The membrane
fusion activity of the mutant GPC was determined using a
␤-galactosidase fusion reporter assay (31) in which syncytium
formation was initiated by exposing the culture of GPC-expressing effector cells and fusion reporter target cells to medium adjusted to pH 5.0 (44, 48). As illustrated in Fig. 2, most
of the alanine mutants in G2 were able to mediate pH-dependent cell-cell fusion at levels approaching (ⱖ50%) that of the
wild type (also see reference 44). Only R392A, E405A, and
R414A were significantly diminished in their membrane fusion
activity (ⱕ20% of the level of wild-type GPC).
Mutations at charged residues complement fusion defects in
SSP. To specifically inquire whether these charged residues in
G2 interact with SSP, we screened the panel of mutants for
their ability to rescue a fusion deficiency at SSP position 33.
This genetic method of complementation is frequently used to
study functional interactions between and within viral proteins
(5, 39). Of the previously characterized K33 mutants, only
K33Q GPC is severely debilitated yet retains sufficient activity
at pH 5.0 (6% of the wild type) for experimental measurements of complementation. Mutations in G2 that restored
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FIG. 3. Membrane fusion activity of charge mutants at R414.
These studies were performed in the same fashion as those described
in the legend to Fig. 2. The amino acid changes at R414 are indicated
by single-letter abbreviations. Note that the vertical axis is truncated.
wt, wild type.

fusion activity beyond this 6% baseline level were judged to
interact genetically with SSP. We identified four such mutations (Fig. 2). Double mutants with D400A, E410A, R414A,
and K417A were able to mediate fusion at 20, 30, 55, and 20%
of wild-type levels, respectively. In contrast, little or no increase in fusion activity was observed in double mutants containing D390A, R392A, D394A, E398A, E405A, K409A,
D413A, or D424A. The presence or absence of complementation
did not correlate with the magnitude of the fusion defect in the
single alanine mutant. Nor could we discern significant differences
in the extent of SSP association or proteolytic maturation (45)
among the mutant GPC complexes (not shown). Selective
complementation by the D400A, E410A, R414A, and K417A
mutations, all of which cluster toward the membrane-spanning
domain of G2, points to specificity in the rescue. These findings
indicate a genetic interaction between SSP and the most membrane-proximal region of the G2 ectodomain.
Molecular basis for complementation of K33Q. To investigate whether complementation involves pH-sensitive interactions, we examined a series of charge mutants at the strongly
complementing R414 position. As anticipated, R414E was
somewhat reduced in membrane fusion activity relative to that
of R414A and with respect to R414K, R414H, R414Q, and
R414S mutants (Fig. 3). However, none of the charged, polar,
or neutral mutations had major effects on the membrane fusion activity or complementation of K33Q. A difference in the
extent of rescue by the R414 mutation generally correlated
with its effect on fusion activity. In contrast to the systematic
effects of mutation at K33, we were unable to discern a chargedependent interaction between K33Q and the R414 side chain.
Thus, complementation by K33Q may arise through effects
other than those that are determined primarily by charge.
Compared to that of wild-type GPC, K33Q requires a lower
pH to activate membrane fusion (47). With the extraordinary
stability of the G1 and G2 association in the K33A mutant (44),
we concluded that mutations at K33 stabilize the native GPC
complex with respect to pH-induced activation. Therefore, we
hypothesized that K33Q-complementing mutations in G2 act
in an opposing manner to destabilize the complex and raise
the pH for membrane fusion. Initial experiments with three of
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FIG. 4. pH sensitivity of membrane fusion. Cells expressing either wild-type SSP (black circles) or K33Q SSP (black squares) with the G2
mutant were pulsed at the indicated pH. The lightly shaded curves, repeated in all panels, depict fusion of the wild-type CD4sp-GPC with wild-type
(gray circles) and K33Q (gray squares) SSP. The results shown in this study are representative of at least three independent experiments. Fusion
activity is normalized to the maximum of each mutant for this comparison. Error bars represent ⫾1 standard deviation.

these mutations (D400A, E410A, and K417A) had not revealed significant differences (44), so we extended the analysis
to include the strongly complementing R414A mutation.
The pH dependence of membrane fusion was determined by
varying the pH of the acidic medium used to initiate cell-cell
fusion (44, 47). Fusion activity by the wild-type GPC (Fig. 4)
was first observed at pH 5.5, attained a maximum level at pH
5.0, and subsequently declined (gray circles). As noted, fusion
by K33Q GPC (gray squares) was minimal at pH 5.0 and
reached its maximum level at pH 4.5. Single mutants with
complementing (E410A and R414A) and noncomplementing
(E405A and D424A) mutations behaved much like the wildtype GPC, with maximal fusion activity at pH 5.0 to 5.5 (black
circles). Although small differences relative to the wild type
could be noted, these did not correlate with the presence or
absence of complementation and were not statistically significant in our studies. Thus, the single alanine mutations in the
membrane-proximal ectodomain of G2 did not by themselves
increase the pH at which membrane fusion is activated.
Complementing mutants abolish pH suppression by K33Q.
However, all of the complementing mutations, and only the
complementing mutations, were able to mitigate the K33Qinduced reduction in the pH of activation (Fig. 4). In the highly
complementing R414A mutant, maximal membrane fusion was
shifted to pH 5.0 (black squares), similar to that of wild-type
GPC and distinct from that of the single K33Q mutant (pH
4.5). The weakly complementing E410A mutant showed a partial shift toward pH 5.0. In contrast, optimal fusion by noncomplementing double mutants (E405A and D424A) remained at pH 4.5, similar to K33Q GPC. Thus, the rescue of
the membrane fusion activity of K33Q GPC by second-site
mutations in G2 can be accounted for entirely by their sup-

pression of the K33Q-induced decrease in the pH of membrane fusion.
Role of the G2 membrane-spanning domain in complementation. Several lines of evidence suggested that interactions
between SSP and G2 extend to the membrane-spanning region. In particular, amino acid determinants of resistance to
small-molecule fusion inhibitors recently discovered by SIGA
Technologies (Corvallis, OR) are localized not only in the
ectodomain loop of SSP and the membrane-proximal ectodomain of G2 but also in the adjoining transmembrane domain
(3, 27, 44). We therefore extended our complementation analysis to include transmembrane residues in G2 known to affect
sensitivity to these inhibitors. As shown in Fig. 5, mutations at
two major determinants of resistance (F427A and F438I) were
able to rescue the K33Q defect to 50 and 75% of wild-type
levels, respectively. A435I, another resistance mutation, did
not complement K33Q, whereas the inhibitor-sensitive mutant
W428A did. Thus, the interactions responsible for the complementation of K33Q extend into the membrane-spanning domain of G2 and are not restricted to charged residues.
Interestingly, the mechanism for complementation at these
hydrophobic positions (F427 and W428) appeared identical to
that at charged positions in the membrane-proximal ectodomain. Neither of these uncharged mutations alone affected the
pH of membrane fusion, yet both restored the pH of the
maximal fusion activity of K33Q GPC to that of the wild type
(Fig. 4). Complementation at these hydrophobic positions is
unlikely to be mediated by direct interaction with K33. Rather,
the restoration of the wild-type phenotype may reflect indirect
structural effects emanating from interactions of the membrane-spanning domains of G2 and SSP or from potential
oligomerization determinants in G2 (16, 32). Thus, perturba-
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FIG. 5. Complementation by transmembrane domain G2 mutants.
The G2 mutants were expressed in trans with wild-type SSP (open
bars) or K33Q SSP (filled bars), and membrane fusion activity was
determined. These data represent one complete study (of at least three
complete and partial experiments).

tions in the membrane may couple to the pH-sensing ectodomain.
Additional transmembrane domain residues that might be
involved in complementation were also examined. The possibility of a transient disulfide bond at C426 and the potentially
ionizable H440 side chain were probed by replacements with
serine and alanine, respectively. Neither of these mutations
disrupted fusion activity or complemented the K33Q defect
(Fig. 5). The H440A mutation eliminated the sole histidine in
the membrane and membrane-proximal sequences of G2.
Controlled activation of pH-induced membrane fusion. Our
observation that complementing mutations, which alone do
not affect the pH of membrane fusion, are able to abrogate the
pH effect of the K33Q mutation presents us with a conundrum.
In the simplest model for complementation, second-site mutations might generate a corresponding increase in pH sensitivity to counterbalance the reduction by K33Q. Indeed,
compensatory changes in pH sensitivity are well described in
the influenza virus HA. Fusion inhibition by tert-butyl hydroquinone (TBHQ) compounds that stabilize the HA complex against low pH in the endosome can be overcome by
second-site mutations that render it more sensitive to pH (23,
36). Similarly, viral resistance to amantadine, an inhibitor of
endosomal acidification, arises through mutations in HA that
specifically enable fusion at an elevated pH (11, 40). Mutations
affecting the pH of HA activation include both charged and
uncharged residues that, although widely distributed, tend to
cluster near the fusion peptide as well as at monomer interfaces (11, 23, 36, 39–41). Despite atomic resolution knowledge
of HA, however, the primary site of pH-induced activation
remains unresolved (22, 42). In general, the compact and
metastable nature of the native complex makes the dissection
of primary and secondary events in the response to pH difficult.
The molecular mechanism whereby mutations in G2 restore
wild-type pH sensitivity to K33Q GPC without themselves altering the pH of activation is unclear. We suggest that the
original K33Q mutation affects the prefusion complex in two
opposing directions. First, by decreasing repulsive charge interactions through K33, the glutamine mutation may directly
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stabilize the pH-sensing mechanism against activation. Second,
by replacing the natural lysine residue, the mutation also may
contribute to destabilization of the complex. In the single G2
mutants, the pH-sensing mechanism remains intact and responds in the same fashion as the wild-type GPC, despite the
G2 mutation. However, in the double mutant, the effects of the
G2 mutation may combine with the destabilizing component of
the K33Q mutation to overcome the otherwise stabilizing effect of the uncharged glutamine. Nonlinear interactions between mutations affecting pH sensitivity in HA also have been
documented (39). It remains possible that the primary pHresponsive interaction of K33 includes charged residues elsewhere in G2. As illustrated in the recently published structure
of the acid-sensing ion channel ASIC1, pH-sensing sites can be
highly distributed networks including multiple-charge, protonsharing, and hydrogen-bonding interactions (25). It is important to note that the genetic results reported here do not
necessarily connote direct chemical interactions. In the absence of the atomic resolution structure, however, our studies
provide initial insights into the complex structure-function relationships that promote the transition from the native GPC
complex toward membrane fusion.
Without an effective treatment or vaccine, the hemorrhagic
fever arenaviruses remain a pressing public health and biodefense concern. In this regard, it is noteworthy that the process
of the pH-induced activation of membrane fusion has been
shown to offer a viable target for antiviral intervention. In a
manner analogous to that of the TBHQ inhibitors of HA (23,
36), small-molecule arenavirus-specific compounds described
by SIGA (3, 27) inhibit GPC-mediated fusion by stabilizing the
prefusion complex against acidic pH (44). A further understanding of the molecular determinants of inhibition at the
SSP-G2 interface may lead to the identification of improved
antiviral compounds. The genetic manipulation of pH sensitivity also may generate stable forms of the native GPC complex
that can be used to elicit protective immunity as well as in
structural studies. The detailed characterization of GPC-mediated membrane fusion will advance the development of effective vaccines and therapeutic agents against arenaviral disease.
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